Search

Chair: Tonya Bacon
9.00 Cryoprotein analysis – A UK NEQAS update Dina Patel, UK
NEQAS Immunology, Sheffield
9.30 Investigating cryoproteins – are we offering the best service possible?
Dr Rachel Wheeler, South West London Pathology
10.30 Assay trouble shooting – case study
Penny Feather, Scunthorpe General Hospital
11.00 Goodpastures case study
Faye Sims, Peterborough City Hospital
11.30 Breaking news in Immunology
Dr Graeme Wild, Sheffield Teaching Hospitals NHS Foundation Trust

13.30 Influenza-like-Illness testing and its importance as SARS-CoV-2 moves from pandemic to endemic Gavin Wall MSc MBA DipRCPath, Director of Medical Affairs (Infectious Diseases), QIAGEN

13.00 Introducing the PATHFAST™
- Emergency Marker High Sensitivity Troponin I assay into the Emergency Department
Ian Smith, AB Scientific

14.00 Pre-empting problems – may the workforce be with you Charley Frampton, Berkshire & Surrey Pathology Services
15.00 The exit interview – a meaningful goodbye Joanna Frost,
Path Links North Lincolnshire & Goole NHS Foundation Trust
16.00 The importance of good laboratory design on staff health and wellbeing
Ian Cocking, Leeds Teaching Hospitals NHS Trust
16.30 Motivating a tired and exhausted workforce

Chair: Phillipa Burns 14.00 Importance of
oral microbiology Dr Riina Richardson, University of Manchester
14.30 Challenges in diagnosis and management of a case of COVID- associated pulmonary
Aspergillosis (CAPA) on an intensive care unit Jennifer Ratner,
The Mid-Yorkshire Hospitals NHS Trust
15.00 Improving training in parasitology Jemma Mangan-
Casbon, Nottingham Trent University

Chair: Mark Cioni 9.00 Anaerobes – update and important developments Trefor Morris, Public Health Wales
9.30 The great and recurrent
questions regarding Clostridioides dif?cile Michael Perry, Public Health Wales
10.30 Impact of HG3 organisms not
being suspected from clinical resulting in processing at CL2 Michelle Peters, Public Health Wales
11.00 Microbiome- associated metabolites and the gut–brain axis
Prof. Lesley Hoyles, Nottingham Trent University
11.30 Whole-genome sequencing in Microbiology
Prof. Thomas Connor, Cardiff University

Chair: Mike Palmer
14.00 Mapping the genomic architecture of COVID-19, a discovery that may aid in the fight against SARS-CoV-2 infection Dr Yasser El-Sherbiny, Nottingham Trent University
14.30 EUCAST update 2022
Pegah Hafezi, North Bristol NHS Trust
15.00 Antibiotic resistance spillover into wildlife - using birds of prey as signal species
Professor Mark Fielder, Kingston University
16.00 Whats new in mycology?
Prof. Elizabeth Johnson, UK Health Security Agency
16.30 Invasive Magnusiomyces capitatus infection in a patient with neutropenic sepsis Michael Collins, University Hospitals of Derby and Burton
NHS Foundation Trust

Chair: Nicky
Hollowood
14.00 Molecular advances in POCT testing
14.30 CEP in
POCT – value of the qualification
Lee Peters, Swansea Bay University Health Board
15.00 Teaching and training of POCT for non-laboratory staff Michelle Payne, University of Sunderland

Chair: Dr Sarah Glover
9.00 POCT in pathology networks
Lisa Vipond, Royal Cornwall Hospitals NHS Trust
9.30 How COVID-19 has accelerated the POCT landscape David Ryder, University
Hospitals of Morecambe Bay NHS Foundation Trust
10.30 POCT: Benefit to users and practical outcomes for patients
11.00 POCT in the anticoagulant service Leanne Cross and Beverley Straker- Bennett, Blackpool Teaching Hospitals NHS Foundation Trust
11.30 Implementing and managing quality control in a multi- professional POCT team Liz Berry, North Cumbria Integrated Care NHS
Foundation Trust

14.00 Ensuring quality in an emergency situation Jessica Dixon, Milton Keynes University Hospital NHS Foundation Trust
14.30 Remote auditing
David Wilson, IBMS Specialist Advisor, Immunology 15.00 Patient results – are they as accurate as they can be?
Clare Morris, National Institute for Biological Standards and Controls